The role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia.
about
Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolutionAssessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplification.Idelalisib and caffeine reduce suppression of T cell responses mediated by activated chronic lymphocytic leukemia cells.ATM function and its relationship with ATM gene mutations in chronic lymphocytic leukemia with the recurrent deletion (11q22.3-23.2).The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells.TP53 mutation analysis in clinical practice: lessons from chronic lymphocytic leukemia.The molecular pathogenesis of chronic lymphocytic leukaemia.MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?Novel targets for ATM-deficient malignancies.NOD/SCID IL2Rγ-null mouse xenograft model of human p53-mutated chronic lymphocytic leukemia and ATM-mutated mantle cell lymphoma using permanent cell lines.Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenografts.MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis.Biallelic ATM alterations detected at diagnosis identify a subset of treatment-naïve chronic lymphocytic leukemia patients with reduced overall survival similar to patients with p53 deletion.Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia.Post-Translational Modifications of H2A Histone Variants and Their Role in Cancer.
P2860
Q26823586-F8024D1F-B1EC-43F6-B81A-346EDB7A7CBEQ36022313-606C9341-B4F8-45A9-86CA-4A1842B14032Q36296595-591D23C2-3C83-420E-AB37-150353FD4541Q37325003-C2C7B62A-BA01-4CE2-9893-9A12708032ABQ37564440-3C06E39D-BD2B-40CC-B97D-D702BFA8CDA2Q38177771-5A0018DA-15F0-44F3-8E35-A9A8BF7DB2E2Q38748645-68516564-7A0B-4ABE-961C-32F8006BAA84Q38797069-A0199B76-FEBC-4B07-9696-444E0D4A6240Q38866642-BF3A5B86-341B-4C63-9663-30024E8E0475Q38892495-D00DFF5A-4F62-4286-A46D-89A2E5976F4AQ41280348-EEA8D115-60C9-40E6-9A37-52CB57098B24Q49788568-DA2D8904-4E71-4965-B142-427667D64EB0Q51587472-56834B80-7378-45B0-A831-805E1EF2D2CEQ52796916-B55CC42D-AC84-45C6-B965-12DF7C2F9231Q53827263-D3E4806D-A89B-4801-A8FB-990A80E950D3
P2860
The role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The role of ATM mutations and ...... chronic lymphocytic leukemia.
@ast
The role of ATM mutations and ...... chronic lymphocytic leukemia.
@en
type
label
The role of ATM mutations and ...... chronic lymphocytic leukemia.
@ast
The role of ATM mutations and ...... chronic lymphocytic leukemia.
@en
prefLabel
The role of ATM mutations and ...... chronic lymphocytic leukemia.
@ast
The role of ATM mutations and ...... chronic lymphocytic leukemia.
@en
P2860
P1433
P1476
The role of ATM mutations and ...... n chronic lymphocytic leukemia
@en
P2093
Anna Skowronska
P2860
P304
P356
10.3109/10428194.2013.829919
P50
P577
2013-09-12T00:00:00Z